APA (7th ed.) Citation

GÜLBAĞCI, B. B., ÖZEN, M., ENGİN, E. Ö., KAHVECİOĞLU, F. A., ÇİFTÇİ, E., & HACIBEKİROĞLU, İ. Does Delta Hemoglobin-Albumin-Lymphocyte Platelet (HALP) Score Predict the Risk of Early Progression in Patients Treated with CDK4/6 Inhibitors? Galenos Yayincilik.

Chicago Style (17th ed.) Citation

GÜLBAĞCI, Burcu Belen, Miraç ÖZEN, Esra ÖZEN ENGİN, Fatma AKDAĞ KAHVECİOĞLU, Esra ÇİFTÇİ, and İlhan HACIBEKİROĞLU. Does Delta Hemoglobin-Albumin-Lymphocyte Platelet (HALP) Score Predict the Risk of Early Progression in Patients Treated with CDK4/6 Inhibitors? Galenos Yayincilik.

MLA (9th ed.) Citation

GÜLBAĞCI, Burcu Belen, et al. Does Delta Hemoglobin-Albumin-Lymphocyte Platelet (HALP) Score Predict the Risk of Early Progression in Patients Treated with CDK4/6 Inhibitors? Galenos Yayincilik.